Kate Miroshnikova

Dr. Kate Miroshnikova is a Researcher at the Max Planck Institute for Molecular Biomedicine in Münster, Germany. Her work focuses on nuclear mechanotransduction, extracellular matrix mechanics, and their roles in cancer progression, stem cell fate, and transcriptional kinetics. She is actively involved in the "Cells in Motion" (CiM) research network and serves as a supervisor in the CiM-IMPRS Graduate Programme, mentoring doctoral students in interdisciplinary biomedical research. Her research integrates biophysical principles with cellular behavior to understand how mechanical forces influence tissue architecture and disease states like glioblastoma and pancreatic cancer.

Her recent publications highlight the interplay between mechanical forces and cellular responses, including nuclear shape regulation, chromatin remodeling, and tumor aggression. Key themes in her work include:

• Mechanical regulation of nuclear structure and genome integrity
• Extracellular matrix stiffness and cancer initiation
• Role of tissue tension in pancreatic and glioblastoma progression
• Biophysical mechanisms in stem cell fate and epidermal development
• Engineering platforms to study mechanical-ECM interactions

Dr. Miroshnikova's contributions span both fundamental biophysical research and translational applications in tumor biology and tissue engineering. Her work bridges mechanical signaling with molecular pathways, offering insights into mechanopathology and therapeutic targeting.